Business Today US India IPR FDA Pharma Sector
Business Today
Alchemy by E Kumar Sharma
Questions that global generic behemoth Teva's results raise for Indian pharma

On August 3rd, the largest generic company operating in the US, Teva Pharmaceutical Industries (Teva in quickspeak) put out results that arguably jolted the world of global generic medicines.

 
 
But then, there are few questions that need to be addressed to ensure the move leads to maximum benefit for the patients.
UK-based pharma company GlaxoSmithKline and one of the oldest pharma MNC in India, has announced that it will not file for patents in the low income countries.
The passing away of P. Ravindra Reddy, Founder Chairman of Hyderabad-based MTAR Technologies, marks more than an end to an eventful journey.
 
 
High profile investment melas by Indian states, backed by big numbers to showcase potential investor interest, are par-for-the-course today.
Water, as things stand today, is a state subject even though ground water management is a national priority.
Global drug development history has its examples of instances where red flags were raised, which later turned out to be red herrings.
Advertisement